These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4388838)

  • 21. [Effect of new pyrazolo-(1,2-a)-1,2,5-triazepine derivatives on the central nervous system].
    Szadowska A; Mazur M; Kamińska A; Kusowska J; Winer A
    Acta Pol Pharm; 1982; 39(5-6):463-67. PubMed ID: 7171016
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacologic study of certain sulfhydrazide and diacylhydrazine derivatives].
    Cuparencu B; Safta L; Cojocaru Z; Pitea M; Barzu T; Ghiran D; Ticsla I
    J Physiol (Paris); 1968; 60 Suppl 2():426. PubMed ID: 5734956
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of histamine on the catatonia induced in mice by tetrabenazine and reserpine.
    Cesare LC; Carlini GR; Carlini EA
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):26-34. PubMed ID: 4964216
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the pharmacology of the new psychoactive drug 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (Ro5-4556)].
    Randall LO; Schallek W; Scheckel C; Banziger R; Moe RA
    Arzneimittelforschung; 1968 Dec; 18(12):1542-5. PubMed ID: 4975663
    [No Abstract]   [Full Text] [Related]  

  • 26. Some pharmacologic properties of thozalinone, a new excitant.
    Greenblatt EN; Osterberg AC
    Toxicol Appl Pharmacol; 1965 Jul; 7(4):566-78. PubMed ID: 4378772
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the EEG of the reserpinized rabbit caused by psychoanaleptics and precursors of biogenic amines].
    Nakajima H; Thuillier J
    Med Pharmacol Exp Int J Exp Med; 1966; 14(2):161-8. PubMed ID: 4379405
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological evaluation of a potential psychotherapeutic agent: cyprolidol, a pyridylcyclopropane derivative.
    Miller L; Napoli M; O'Dell TB
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):313-23. PubMed ID: 4963240
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral and neurochemical characteristics of stimulant-induced augmentation.
    Segal DS; Kuczenski R
    Psychopharmacol Bull; 1987; 23(3):417-24. PubMed ID: 2893420
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurotropic properties of aminooxyacetic acid and gamma-aminooxybutyric acid].
    Ostrovskaia RU; Artemenko GN; Raevskii KS
    Farmakol Toksikol; 1970; 33(2):137-42. PubMed ID: 4393231
    [No Abstract]   [Full Text] [Related]  

  • 31. The evaluation of central nervous system stimulants in a new laboratory test for antidepressants.
    Sanghvi I; Gershon S
    Life Sci; 1969 May; 8(9):449-57. PubMed ID: 4389344
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of prolintane in rats and the effect of prolintane metabolites on general activities in mice.
    Yoshihara S; Yoshimura H
    Xenobiotica; 1974 Sep; 4(9):529-35. PubMed ID: 4154540
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 36. The neuropharmacology of 2-(omicron-chlorophenyl)-2-methylaminocyclohexanoe hydrochloride.
    Chen G; Ensor CR; Bohner B
    J Pharmacol Exp Ther; 1966 May; 152(2):332-9. PubMed ID: 4380271
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the pharmacology of syndnone and syndonimine. A survey].
    Ackermann E
    Pharmazie; 1967 Oct; 22(10):537-42. PubMed ID: 4387100
    [No Abstract]   [Full Text] [Related]  

  • 38. [Activity of Tephrosia vogelii, ichthyotoxic Papillonaceae from Madagascars on the central nervous system].
    Lefournier C; Ratsimamanga S; Chalopin H; Loiseau A; Rajoharison S
    C R Seances Acad Sci D; 1980 Jan; 290(3):219-22. PubMed ID: 6768461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic properties of the dilactone of bis-(beta-hydroxypropyl)-malonic acid.
    Pelczarska A; Prastowski W
    Arch Immunol Ther Exp (Warsz); 1967; 15(6):912-9. PubMed ID: 5586112
    [No Abstract]   [Full Text] [Related]  

  • 40. On certain correlations between the cholinolytics, the convulsive reactivity of the central nervous system, and the anticonvulsive activity of the anticonvulsants. II. Communication: cholinolytics upon corazol, strychnine, and thiosemicarbazide convulsions.
    Roussinov KS
    Izv Inst Fiziol (Sofiia); 1970; 13():47-62. PubMed ID: 4402013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.